戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s (NASH) is the most common liver disease in industrialized countries.
2  part of monitoring HIV-infected patients in industrialized countries.
3 rrhea and endemic diarrhea in developing and industrialized countries.
4 Ulcerative colitis is most common in Western industrialized countries.
5  is a major cause of disability and death in industrialized countries.
6  most common gynecological cancer in Western industrialized countries.
7 ns the leading cause of skin cancer death in industrialized countries.
8 associated with measles eradication in seven industrialized countries.
9 r disease is the principal cause of death in industrialized countries.
10 s is a major cause of food-borne diseases in industrialized countries.
11 es of immune dysregulation are increasing in industrialized countries.
12 ere these conditions are more common than in industrialized countries.
13 hese diseases are increasing in frequency in industrialized countries.
14 th aging differs across social groups within industrialized countries.
15 rted recently in the United States and other industrialized countries.
16 (HEV) is endemic in many developing and some industrialized countries.
17 hich affects nearly 10% of the population in industrialized countries.
18 sease, one of the leading causes of death in industrialized countries.
19 e is a major cause of nosocomial diarrhea in industrialized countries.
20 loping countries and is also endemic in many industrialized countries.
21 pically >/=100-fold higher than rates in the industrialized countries.
22    Allergic diseases have been increasing in industrialized countries.
23 most developing countries than in infants in industrialized countries.
24 t common form of acute viral encephalitis in industrialized countries.
25                Asthma has been increasing in industrialized countries.
26 ed copper from the typical diets consumed in industrialized countries.
27 ty, is also a major determinant of health in industrialized countries.
28  data set based on breast-fed infants in six industrialized countries.
29 esophageal/gastric cardia adenocarcinomas in industrialized countries.
30 are largely based on the experience of a few industrialized countries.
31 is the most common chronic liver disorder in industrialized countries.
32 als has virtually eliminated human rabies in industrialized countries.
33 d 2008 and is higher than that in many other industrialized countries.
34 sthma occur at higher rates in developed and industrialized countries.
35 count for nearly 10% of all cancer deaths in industrialized countries.
36 oping countries as well as sporadic cases in industrialized countries.
37 ge SCCP stocks are present in urban areas of industrialized countries.
38 e prevalent in 1% to 3% of adults in Western industrialized countries.
39 loping countries and is also endemic in many industrialized countries.
40  has been observed with growing incidence in industrialized countries.
41 r cause of acute hepatitis in developing and industrialized countries.
42 asingly important cause of genital herpes in industrialized countries.
43 t leading cause of blindness in adulthood in industrialized countries.
44 f children and approximately 5% of adults in industrialized countries.
45 cer mortality in the United States and other industrialized countries.
46 lergens constitute a major health problem in industrialized countries.
47 g world, and the indirect economic impact on industrialized countries.
48 roprevalences of 0.3%-53% were reported from industrialized countries.
49 se becomes necessary as has been the case in industrialized countries.
50 ent systems that have been widely adopted in industrialized countries.
51  now ubiquitous in the serum of residents of industrialized countries.
52 to 20% of children and 1% to 3% of adults in industrialized countries.
53 health problems with increasing incidence in industrialized countries.
54  prevalence of allergic diseases observed in industrialized countries.
55 us (HEV) infection is an emerging disease in industrialized countries.
56 e is the third most common cause of death in industrialized countries.
57 is the most frequent occupational disease in industrialized countries.
58 ts acquired from companion animals (cats) in industrialized countries.
59 n enteric infections, in both developing and industrialized countries.
60 common, accounting for 1-2% of all deaths in industrialized countries.
61  extent than that seen in clinical trials in industrialized countries.
62 is one of the most common causes of death in industrialized countries.
63 des with the obesity epidemic, especially in industrialized countries.
64 o of life, although uncommon, is observed in industrialized countries.
65 nation affect up to 20% of the population in industrialized countries.
66 d as a diarrhoeal pathogen in developing and industrialized countries.
67 times higher in developing countries than in industrialized countries (150/100,000 children/year vers
68  from repeated cross-sectional surveys of 10 industrialized countries (38 nationally representative t
69 apita carbon footprint of infrastructures in industrialized countries (53 (+/- 6) t CO2) was approxim
70 ls/d is the most common pattern of eating in industrialized countries, a scientific rationale for thi
71 t commonly diagnosed malignancy among men in industrialized countries, accounting for the second lead
72 lly causes diarrhea in humans, especially in industrialized countries, adapting a more host-restricte
73           Though nearly 2 dozen studies from industrialized countries address this subject, this arti
74 lations in developing countries, children in industrialized countries also benefit from increasing kn
75 rs' diarrhea in visitors to these areas from industrialized countries, although the relative importan
76 ountries: approximately 100-600 kg/capita in industrialized countries and below 100 kg/capita in deve
77 n to be successful around the globe, in both industrialized countries and developing nations.
78  respective prevalence estimates obtained in industrialized countries and in selected less developed
79 s the most prevalent nutritional disorder in industrialized countries and is a growing problem in dev
80  (NAFLD) is the most common liver disease in industrialized countries and is increasing in prevalence
81 D) remains the leading cause of mortality in industrialized countries and is rapidly becoming a prima
82  the leading cause of childhood blindness in industrialized countries and is the fifth leading cause
83 nsion affects approximately 30% of adults in industrialized countries and is the major risk factor fo
84 the African meningitis belt is lower than in industrialized countries and is very diverse and dynamic
85  Prostate cancer is a very common disease in industrialized countries and it is known to be androgen-
86  (NAFLD) is the most common liver disease in industrialized countries and may proceed to steatohepati
87 the leading causes of blindness in adults in industrialized countries and the emerging cause of blind
88 ng proportion of iron-replete individuals in industrialized countries and the possible increased risk
89 ewater treatment system (WWTS) located in an industrialized country and consisting of primary, second
90 why skill demands have persistently risen in industrialized countries, and considers the economic val
91     It is one of the most common diseases in industrialized countries, and in the United States accou
92 lar virology of HEV, mode of transmission in industrialized countries, and potential implications for
93 hods, a large percentage of children in many industrialized countries are being tested as a being at
94       Although most HIV-infected children in industrialized countries are immigrants with a relativel
95 ted in the increase of obesity and cancer in industrialized countries but are poorly understood.
96 cently, hepatitis E was rarely identified in industrialized countries, but Hepatitis E now is reporte
97 c diseases represent a significant burden in industrialized countries, but why and how the immune sys
98                                           In industrialized countries Candida albicans is considered
99 AD) remains the number one cause of death in industrialized countries despite our collective efforts
100  to well-oxygenated lacustrine conditions in industrialized countries despite the implementation of r
101  leading cause of morbidity and mortality in industrialized countries, especially in the elderly.
102 found in descriptions of patients treated in industrialized countries; except for the 2000 outbreak o
103 and good quality health-care system, whereas industrialized countries have a major need for greater p
104                                              Industrialized countries have shown similar patterns of
105 otech to developing nations, scientists from industrialized countries have the heightened responsibil
106 ies, mostly from the United States and other industrialized countries, have examined the associations
107 irus (HEV) infection can also be acquired in industrialized countries-HEV genotype 3 infection is a z
108         On the basis of measles dynamics for industrialized countries, high birth rate regions should
109 ppendicitis or appendectomy is high in newly industrialized countries in Asia (South Korea pooled: 20
110 and gastric cardia have sharply increased in industrialized countries in recent decades.
111 and drug use, depression and suicide in most industrialized countries in the decades following the Se
112  Asia and Africa and is also endemic in many industrialized countries, including the United States.
113              Recent reports from a number of industrialized countries indicate that the proportion of
114                      The obesity epidemic in industrialized countries is associated with increases in
115 urden of allergic and autoimmune diseases in industrialized countries is inappropriate immune develop
116                              Data from newly industrialized countries is sparse, but suggests that ap
117  as in other developing countries but unlike industrialized countries, is delivered as a 3-dose prima
118 diarrhea in the United States and many other industrialized countries, is recognized as a major healt
119 hough the disease has been declining in most industrialized countries, it remains the second most com
120 istribution of POPs in densely populated and industrialized countries located in temperate regions.
121       Compared to present car utilization in industrialized countries, massive deployment of prototyp
122 sts that the resurgence of pertussis in many industrialized countries may result from the failure of
123 stic leukemia (ALL) are now over 80% in most industrialized countries, not all children have benefite
124                                           In industrialized countries, [O(3)] has risen by 0.5% to 2.
125                                           In industrialized countries, persons infected sexually with
126   This data set, representative of an entire industrialized country, presents a reference point for c
127  prematurity and cardiopulmonary diseases in industrialized countries, primarily affect term infants
128                  One-fourth of all deaths in industrialized countries result from coronary heart dise
129                                           In industrialized countries, rotavirus vaccination has led
130                       Population profiles of industrialized countries show dramatic increases in card
131 tis were higher than estimates reported from industrialized countries, such as Australia, New Zealand
132 ngly, the diseases of particular concern for industrialized countries--such as type 2 diabetes, obesi
133 tock saturates at 8-12 tons as evidence from industrialized countries suggests, consumption may peak
134 ong children <2 years of age, while those in industrialized countries tended to occur in older person
135 allergic conditions among children living in industrialized countries than those in developing region
136 EVIEW: There is something about living in an industrialized country that dramatically increases the r
137  rate is similar (approximately 10%) in most industrialized countries; the illness has a large econom
138 ection account for about 2% of all deaths in industrialized countries; they are also components of se
139  recommended strategy in a growing number of industrialized countries, to protect young infants from
140                                              Industrialized countries (USA, UK, Germany, Japan, Italy
141  of 2 populations from nonindustrialized and industrialized countries using identical methods and the
142 ome vaccines have proven highly effective in industrialized countries where the disease burden is low
143 appears to be an emerging problem in several industrialized countries, where it is mostly associated
144 y increase the risk or severity of asthma in industrialized countries whereas vitamin A deficiency co
145  differ significantly between developing and industrialized countries, which calls into question the
146               By investing in global health, industrialized countries will not only benefit populatio
147 to affect more than 30% of the population in industrialized countries with a still increasing inciden
148                                           In industrialized countries with a Western lifestyle, sensi
149 in rural China than in asthmatic subjects in industrialized countries with a Western lifestyle.
150                                           In industrialized countries with established Hib vaccinatio
151  Crohn's disease is most prevalent in highly industrialized countries with temperate climates.
152 tality is beyond the peacetime experience of industrialized countries, with a 5-year decline in life

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top